How Much Did ZBiotics Raise?
Funding & Key Investors

ZBiotics, a biotechnology firm specializing in genetically engineered probiotics, has secured $12M in total capital. The company recently announced a significant strategic investment of $12M, marking a pivotal moment in its growth trajectory. This latest financing round underscores the increasing investor confidence in ZBiotics' innovative approach to enhancing daily wellness through advanced biological solutions.

What is ZBiotics?

ZBiotics
ManufacturingHealth & Nutrition ProductsBusiness Services

ZBiotics is at the forefront of biotechnology, developing genetically engineered probiotics designed to improve everyday life. Their innovative product line includes Pre-Alcohol, engineered to break down acetaldehyde and mitigate hangover effects, and Sugar-to-Fiber, which converts dietary sugars into beneficial gut fiber. By targeting health-conscious consumers, ZBiotics is redefining the application of biotechnology in personal wellness, aiming to shift the public perception of its potential in everyday health solutions.

How much funding has ZBiotics raised?

ZBiotics has raised a total of $12M across 1 funding round:

2024

Series A

$12M

Series A (2024): $12M with participation from SpringTide Ventures, Seamless Capital, and Seaside Ventures

Key Investors in ZBiotics

SpringTide Ventures

SpringTide Ventures is a venture capital firm that specializes in leading early-stage financings for innovative healthcare companies, focusing on supporting health-tech founders and advancing technology to enhance care delivery globally.

Seamless Capital

Seamless Capital operates within the Commercial & Residential Construction industry, indicating a potential interest in the operational or infrastructure aspects supporting ZBiotics' growth.

Seaside Ventures

Seaside Ventures focuses on identifying unique opportunities to enhance the value of existing direct-to-consumer (DTC) brands, suggesting a strategic interest in ZBiotics' consumer-facing product strategy.

What's next for ZBiotics?

With the recent influx of major enterprise-level funding and a strategic investment, ZBiotics is poised for significant expansion. This capital infusion is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach. The company's focus on science-backed wellness solutions positions it for continued growth in the burgeoning health-tech sector. Future endeavors will likely involve further research into novel probiotic applications and strategic partnerships to solidify its market leadership.

See full ZBiotics company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturingIndustrial Machinery & Equipment
Building MaterialsManufacturingConstruction ManagementConstruction
Industrial Machinery & EquipmentManufacturingArchitecture, Engineering & DesignConstruction
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding ZBiotics Financial Insights

What are the most recent funding rounds that ZBiotics has completed, and what were the funding rounds?
ZBiotics has recently completed 1 funding rounds: Series A on Aug 27, 2024.
What is the total amount of funding ZBiotics has raised to date?
ZBiotics has raised a total of $12M in funding to date.
How many funding rounds has ZBiotics completed?
ZBiotics has completed 1 funding rounds.
How much funding did ZBiotics raise in its most recent funding round?
ZBiotics raised $12M in its most recent funding round.
Who are the lead investors in ZBiotics's latest funding round?
The lead investor in ZBiotics's latest funding round was SpringTide Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in ZBiotics's history?
The largest funding round in ZBiotics's history was $12M.
See more information about ZBiotics